Related Experiment Videos
Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human
Gokhan Yildiz1, Ayca Arslan-Ergul, Sevgi Bagislar
1BilGen Genetics and Biotechnology Center, Department of Molecular Biology and Genetics, Bilkent University, Ankara, Turkey.
Abstract:
Senescence is a permanent proliferation arrest in response to cell stress such as DNA damage. It contributes strongly to tissue aging and serves as a major barrier against tumor development. Most tumor cells are believed to bypass the senescence barrier (become "immortal") by inactivating growth control genes such as TP53 and CDKN2A. They also reactivate telomerase reverse transcriptase. Senescence-to-immortality transition is accompanied by major phenotypic and biochemical changes mediated by genome-wide transcriptional modifications. This appears to happen during hepatocellular carcinoma (HCC) development in patients with liver cirrhosis, however, the accompanying transcriptional changes are virtually unknown. We investigated genome-wide transcriptional changes related to the senescence-to-immortality switch during hepatocellular carcinogenesis. Initially, we performed transcriptome analysis of senescent and immortal clones of Huh7 HCC cell line, and identified genes with significant differential expression to establish a senescence-related gene list. Through the analysis of senescence-related gene expression in different liver tissues we showed that cirrhosis and HCC display expression patterns compatible with senescent and immortal phenotypes, respectively; dysplasia being a transitional state. Gene set enrichment analysis revealed that cirrhosis/senescence-associated genes were preferentially expressed in non-tumor tissues, less malignant tumors, and differentiated or senescent cells. In contrast, HCC/immortality genes were up-regulated in tumor tissues, or more malignant tumors and progenitor cells. In HCC tumors and immortal cells genes involved in DNA repair, cell cycle, telomere extension and branched chain amino acid metabolism were up-regulated, whereas genes involved in cell signaling, as well as in drug, lipid, retinoid and glycolytic metabolism were down-regulated. Based on these distinctive gene expression features we developed a 15-gene hepatocellular immortality signature test that discriminated HCC from cirrhosis with high accuracy. Our findings demonstrate that senescence bypass plays a central role in hepatocellular carcinogenesis engendering systematic changes in the transcription of genes regulating DNA repair, proliferation, differentiation and metabolism.
Insights
Cellular senescence, a key aging factor, is bypassed during liver cancer development. This study identifies key gene expression changes linked to this senescence-to-immortality switch in hepatocellular carcinoma.
Area of Science:
- Molecular Biology
- Oncology
- Genomics
Background:
- Cellular senescence is a permanent cell cycle arrest crucial for aging and tumor suppression.
- Tumor cells often evade senescence by inactivating key genes (e.g., TP53, CDKN2A) and reactivating telomerase, leading to immortality.
- The transition from senescence to immortality involves significant transcriptional changes, particularly during hepatocellular carcinoma (HCC) development in liver cirrhosis patients.
Purpose of the Study:
- To investigate genome-wide transcriptional alterations during the senescence-to-immortality switch in hepatocellular carcinogenesis.
- To identify gene expression patterns distinguishing senescent and immortal phenotypes in liver tissues.
- To develop a diagnostic signature for differentiating HCC from cirrhosis.
Main Methods:
- Transcriptome analysis of senescent and immortal HCC cell line clones (Huh7) to identify differentially expressed genes.
- Analysis of senescence-related gene expression in various liver tissue types (cirrhosis, dysplasia, HCC).
- Gene set enrichment analysis to understand the functional roles of differentially expressed genes.
- Development and validation of a 15-gene signature test.
Main Results:
- Cirrhosis and HCC tissues exhibit gene expression patterns consistent with senescent and immortal phenotypes, respectively, with dysplasia as a transitional state.
- Senescence-associated genes are enriched in non-tumor, less malignant, and differentiated cells.
- Immortality-associated genes are upregulated in HCC, more malignant tumors, and progenitor cells.
- Genes involved in DNA repair, cell cycle, telomere extension, and amino acid metabolism are upregulated in HCC and immortal cells.
- Genes related to cell signaling and various metabolic pathways are downregulated in HCC and immortal cells.
- A 15-gene signature accurately discriminated HCC from cirrhosis.
Conclusions:
- Senescence bypass is a critical event in hepatocellular carcinogenesis, driving widespread transcriptional reprogramming.
- Distinct gene expression profiles characterize senescent (cirrhosis) and immortal (HCC) states in the liver.
- The identified 15-gene signature holds potential for accurate HCC diagnosis from cirrhosis.
Related Concept Videos
Replicative Cell Senescence
Cell Specific Gene Expression
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Inheritance of Chromatin Structures
General Transcription Factors